Your browser doesn't support javascript.
loading
A comprehensive review about the utilization of immune checkpoint inhibitors and combination therapy in hepatocellular carcinoma: an updated review.
Sharafi, Faezeh; Hasani, Sadegh Abaei; Alesaeidi, Samira; Kahrizi, Mohammad Saeed; Adili, Ali; Ghoreishizadeh, Shadi; Shomali, Navid; Tamjidifar, Rozita; Aslaminabad, Ramin; Akbari, Morteza.
Afiliación
  • Sharafi F; Student Research Committee, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
  • Hasani SA; Cancer Research Center, Department of General Surgery, Shahid Beheshti University of Medical Science, Tehran, Iran.
  • Alesaeidi S; Department of Internal Medicine and Rheumatology, Rheumatology Research Center, Tehran University of Medical Sciences, Tehran, Iran.
  • Kahrizi MS; Alborz University of Medical Sciences, Karaj, Iran.
  • Adili A; Senior Adult Oncology Department, Moffitt Cancer Center, University of South Florida, Tampa, Florida, USA.
  • Ghoreishizadeh S; Department of Oncology, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Shomali N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Tamjidifar R; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
  • Aslaminabad R; Department of Medical Biochemistry, Faculty of Medicine, Ege University, Izmir, 35100, Turkey.
  • Akbari M; Department of Stem Cell, Institute of Health Sciences, Ege University, Izmir, 35100, Turkey.
Cancer Cell Int ; 22(1): 269, 2022 Aug 23.
Article en En | MEDLINE | ID: mdl-35999569
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Irán
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Guideline Idioma: En Revista: Cancer Cell Int Año: 2022 Tipo del documento: Article País de afiliación: Irán